Mufg Securities Americas Inc. Invests $451,000 in Humana Inc. (NYSE:HUM)

Mufg Securities Americas Inc. bought a new position in Humana Inc. (NYSE:HUM - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 1,778 shares of the insurance provider's stock, valued at approximately $451,000.

A number of other large investors have also recently made changes to their positions in HUM. FPC Investment Advisory Inc. acquired a new stake in shares of Humana in the 4th quarter worth $27,000. Centricity Wealth Management LLC purchased a new stake in Humana during the 4th quarter valued at about $30,000. LFA Lugano Financial Advisors SA grew its stake in shares of Humana by 56.3% in the 4th quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock valued at $32,000 after buying an additional 45 shares during the period. OFI Invest Asset Management acquired a new stake in Humana during the fourth quarter worth $33,000. Finally, Transce3nd LLC acquired a new position in shares of Humana in the 4th quarter worth approximately $38,000. 92.38% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on the stock. JPMorgan Chase & Co. decreased their price objective on shares of Humana from $257.00 to $256.00 and set a "neutral" rating for the company in a research report on Tuesday, February 18th. Robert W. Baird increased their price objective on Humana from $270.00 to $300.00 and gave the stock a "neutral" rating in a research report on Tuesday, April 15th. Barclays upped their target price on Humana from $270.00 to $322.00 and gave the company an "equal weight" rating in a report on Friday, April 11th. Morgan Stanley decreased their price objective on Humana from $301.00 to $285.00 and set an "equal weight" rating on the stock in a research note on Wednesday, February 12th. Finally, Oppenheimer increased their target price on Humana from $300.00 to $310.00 and gave the stock an "outperform" rating in a research report on Thursday, May 1st. Seventeen equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat.com, Humana currently has an average rating of "Hold" and a consensus price target of $286.81.

Humana Stock Up 3.9%

Humana stock traded up $9.20 during trading on Monday, reaching $247.16. 2,094,086 shares of the company's stock were exchanged, compared to its average volume of 1,768,621. Humana Inc. has a 52-week low of $212.45 and a 52-week high of $406.46. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The firm has a market cap of $29.83 billion, a price-to-earnings ratio of 24.84, a PEG ratio of 2.05 and a beta of 0.49. The company's 50-day moving average is $262.94 and its two-hundred day moving average is $269.57.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $10.07 by $1.51. Humana had a net margin of 1.02% and a return on equity of 11.70%. The business had revenue of $32.11 billion during the quarter, compared to analysts' expectations of $32 billion. During the same period last year, the firm posted $7.23 earnings per share. The business's revenue was up 8.4% on a year-over-year basis. On average, analysts predict that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.43%. The ex-dividend date is Friday, June 27th. Humana's dividend payout ratio is presently 25.04%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.